William E. Barlow

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S. Albain, William E. Barlow, Steven Shak et al. · The Lancet Oncology · 2009 · 1.4K citations · Full text

Medicine, Oncology, Breast Oncology +12

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

Clifford A. Hudis, William E. Barlow, Joseph P. Costantino et al. · Journal of Clinical Oncology · 2007 · 885 citations · Full text

Medicine, Biostatistics, Oncology +17

Exercise Plus Behavioral Management in Patients With Alzheimer Disease

Linda Teri, Laura E. Gibbons, Susan M. McCurry et al. · JAMA · 2003 · 762 citations · Full text

Medicine, Geriatric Medicine, Rehabilitation Medicine +17

Analysis of Case-Cohort Designs

William E. Barlow, Laura Ichikawa, Dan Rosner et al. · Journal of Clinical Epidemiology · 1999 · 679 citations

Public Health, Biostatistics, Clinical Epidemiology +11

Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

Jeffrey B. Smerage, William E. Barlow, Gabriel N. Hortobágyi et al. · Journal of Clinical Oncology · 2014 · 646 citations · Full text

Medicine, Oncology, Pharmacology +17